ATE556707T1
HT0712 for the treatment of a cognitive deficit
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 8 April 2024, 2.5 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
83 members in 17 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 41050803 | United States of America | A | |
| 2004010876 | United States of America | W |
Members83
| Document | Office | Kind | |
|---|---|---|---|
| WO0213867A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU8479201A | Australia | A | |
| US2002076398A1 | United States of America | A1 | |
| WO0213867A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1355669A2 | European Patent Office (EPO) | A2 | |
| CA2521839A1 | Canada | A1 | |
| WO2004091609A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2004224316A1 | United States of America | A1 | |
| EP1631281A2 | European Patent Office (EPO) | A2 | |
| US2006148813A1 | United States of America | A1 | |
| HK1087351A1 | Hong Kong, China | A1 | |
| JP2006524243A | Japan | A | |
| US2006247252A1 | United States of America | A1 | |
| WO2004091609A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU2007253734A1 | Australia | A1 | |
| CA2653042A1 | Canada | A1 | |
| WO2007137181A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2008051437A1 | United States of America | A1 | |
| US2008188525A1 | United States of America | A1 | |
| WO2007137181A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP2021001A2 | European Patent Office (EPO) | A2 | |
| MX2008014713A | Mexico | A | |
| CN101500559A | China | A | |
| JP2009537568A | Japan | A | |
| EP2116240A1 | European Patent Office (EPO) | A1 | |
| HK1130656A1 | Hong Kong, China | A1 | |
| EP2156831A1 | European Patent Office (EPO) | A1 | |
| US2010286213A9 | United States of America | A9 | |
| US7868015B2 | United States of America | B2 | |
| EP2305353A1 | European Patent Office (EPO) | A1 | |
| EP2316531A1 | European Patent Office (EPO) | A1 | |
| US2011105569A1 | United States of America | A1 | |
| US2011105570A1 | United States of America | A1 | |
| US7947731B2 | United States of America | B2 | |
| EP2340831A1 | European Patent Office (EPO) | A1 | |
| SG172602A1 | Singapore | A1 | |
| US2011190350A1 | United States of America | A1 | |
| US2011224146A1 | United States of America | A1 | |
| US2011224287A1 | United States of America | A1 | |
| EP1355669B1 | European Patent Office (EPO) | B1 | |
| ATE526020T1 | Austria | T1 | |
| EP2377533A2 | European Patent Office (EPO) | A2 | |
| DK1355669T3 | Denmark | T3 | |
| JP4833834B2 | Japan | B2 | |
| BRPI0711816A2 | Brazil | A2 | |
| PT1355669E | Portugal | E | |
| US8097647B2 | United States of America | B2 | |
| ES2373540T3 | Spain | T3 | |
| EP2377533A3 | European Patent Office (EPO) | A3 | |
| US8153646B2 | United States of America | B2 | |
| EP1631281B1 | European Patent Office (EPO) | B1 | |
| ATE556707T1This record | Austria | T1 | |
| US2012196898A1 | United States of America | A1 | |
| HK1159514A1 | Hong Kong, China | A1 | |
| EP2021001B1 | European Patent Office (EPO) | B1 | |
| EP2116240B1 | European Patent Office (EPO) | B1 | |
| EP2156831B1 | European Patent Office (EPO) | B1 | |
| ES2403283T3 | Spain | T3 | |
| ES2403333T3 | Spain | T3 | |
| US8455538B2 | United States of America | B2 | |
| US2013164721A1 | United States of America | A1 | |
| ES2412481T3 | Spain | T3 | |
| AU2007253734B2 | Australia | B2 | |
| US2013274704A1 | United States of America | A1 | |
| CN101500559B | China | B | |
| CA2521839C | Canada | C | |
| EP2340831B1 | European Patent Office (EPO) | B1 | |
| ES2509093T3 | Spain | T3 | |
| SG10201407258RA | Singapore | A | |
| JP2015042667A | Japan | A | |
| US2015141441A1 | United States of America | A1 | |
| IL195295A | Israel | A | |
| US9241925B2 | United States of America | B2 | |
| US9254282B2 | United States of America | B2 | |
| CA2653042C | Canada | C | |
| US9408830B2 | United States of America | B2 | |
| CY1116647T1 | Cyprus | T1 | |
| US2017143685A1 | United States of America | A1 | |
| US2017224845A9 | United States of America | A9 | |
| US9795591B2 | United States of America | B2 | |
| US2018021299A9 | United States of America | A9 | |
| US9931318B2 | United States of America | B2 | |
| US10188640B2 | United States of America | B2 |
Numbers
- Application
- 4759288
Titles2
- German
- PHOSPHODIESESTERASE 4 INHIBITOREN ZUR BEHANDLUNG EINES KOGNITIVEN DEFIZITS
- English
- PHOSPHODIESESTERASE 4 INHIBITORS FOR THE TREATMENT OF COGNITIVE DEFICIT
Classification
- CPC, 16
- A61K31/4015
- A61K31/00
- A61K31/519
- A61K38/1709
- A61K45/06
- A61K48/00
- A61P25/00
- A61P25/14
- A61P25/16
- A61P25/18
- A61P25/24
- A61P25/28
- A61P35/00
- A61P43/00
- A61P9/00
- A61P9/10
- IPC, 6
- A61K31 00
- A61K31 4015
- A61K38 17
- A61K45 06
- A61K48 00
- A61P25 28